Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 81 - 225 sur 338 résultats.

Pages

    • Communication
    Invited lecture: Tumor antigens recognized by T cells: perspectives for cancer vaccines
    Van den Eynde, Benoît[UCL] Chaux, Pascal[UCL] Morel, Sandra[UCL] van der Bruggen, Pierre[UCL] De Giovanni, G.[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) 13th Annual Society for Biological Therapy Meeting — Pittsburg, USA
    • Communication
    Invited lecture: Processing of human tumor antigens by the proteasome
    Van den Eynde, Benoît[UCL] (2013) Processing of human tumor antigens by the proteasome — Keio University, Japan
    • Article de périodique
    New tumor-antigens recognized by T-cells
    Van den Eynde, Benoît[UCL] Brichard, Vincent G.[UCL] (1995) Current Opinion in Immunology — Vol. 7, no. 5, p. 674-681 (1995)
    • Communication
    Invited lecture: Antigenic peptides produced by peptide splicing in the proteasome
    Van den Eynde, Benoît[UCL] (2005) The French Society of Immunology Annual meeting being held jointly with the French Club of Dendritic Cells — Toulouse, France
    • Article de périodique
    Tumor rejection antigens and specific immunotherapy of cancer
    Boon, Thierry[UCL] Brichard, Vincent G.[UCL] Van den Eynde, Benoît[UCL] (1995) Médecine, sciences - MS — Vol. 11, no. 9, p. 1279-1287 (1995)
    • Communication
    Identification of genes encoding T cell defined tum- antigens
    Van Pel, Aline[UCL] De Plaen, Etienne[UCL] Lurquin, Christophe[UCL] Van den Eynde, Benoît[UCL] Lethe, Bernard[UCL] Hainaut, Philippe[UCL] Lemoine, Carine[UCL] Boon-Falleur, Thierry[UCL] (1988) 19th International Symposium of The Princess Takamatsu Cancer Research Fund — Tokyo, Japan
    • Communication
    Invited Lecture: Restoring immune control of cancer
    Van den Eynde, Benoît[UCL] (2014) Symposium — Beijing (China)
    • Communication
    Invited lecture: Mechanisms of tumoral immune resistance
    Van den Eynde, Benoît[UCL] (2009) 2nd International MUGEN Conference on Animal Models for Human Immunological Disease — Athens, Greece
    • Communication
    Invited lecture: The molecular nature of T-cell defined tumor antigens
    Van den Eynde, Benoît[UCL] Chaux, Pascal[UCL] Morel, Sandra[UCL] van der Bruggen, Pierre[UCL] De Giovanni, G.[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) The Robert Steel Foundation International Symposium — New York, USA
    • Communication
    Invited lecture: Genes coding for tumor rejection antigens
    Van den Eynde, Benoît[UCL] (1993) NUCC Symposium on Recent Developments in Oncology. New Developments in tumor immunology: prospects for clinical applications — Nijmegen University Cancer Center, Nijmegen, The Netherlands
    • Communication
    Invited lecture: Antigens recognized by cytolytic T cells on human tumors
    Van den Eynde, Benoît[UCL] (1995) Symposium on Immunotherapy of cancer: antibodies, T cells and gene therapy — Karolinska Institutet, Stockholm, Sweden
    • Article de périodique
    An antigenic peptide produced by reverse splicing and double asparagine deamidation
    Dalet, Alexandre[UCL] Robbins, Paul F. Stroobant, Vincent[UCL] Vigneron, Nathalie[UCL] Li, Yong F. El-Gamil, Mona Hanada, Ken-ichi Yang, James C. Rosenberg, Steven A. Van den Eynde, Benoît[UCL] (2011) Proceedings of the National academy of sciences of the United States of America — Vol. 108, no. 29, p. E323-331 (19/07/2011)
    • Communication
    Invited lecture: Mechanisms of tumoral immune resistance
    Van den Eynde, Benoît[UCL] (2009) Cancer Research Institute Symposium "Control of Cancer Immunosuppression: The Challenge for Cancer Vaccine Development" — New York, USA
    • Communication
    Invited lecture: Antigens recognized by T cells on human tumors
    Van den Eynde, Benoît[UCL] (1999) 4th European Winter Conference in Immunology; "Basis of immune memory: bacterial and tumoral vaccines development" — Saint-Sorlin d'Arves, France
    • Communication
    Invited lecture: Expression of indoleamine 2,3-dioxygenase by tumor cells as an immune resistance mechanism that can be fought
    Van den Eynde, Benoît[UCL] (2007) Molecular Targets in Cancer Immunotherapy. Mechanism and Therapeutic Reversal of Immune Suppression in Cancer — Clearwater, Florida, USA

Pages